MOBILE
TABLET

Insights and Ideas

Whitepapers, case studies, and other helpful resources to support outcomes-based healthcare

Ask Procured Health: Which novel oral anticoagulant is best for venous thromboembolism?

Sept. 18, 2017 Pharmacy Pharmacy Leaders

In talking to healthcare leaders about drug utilization, I’ve fielded many questions concerning the application of clinical evidence to specific drugs and drug categories. I address one popular topic below.

DEAR PROCURED HEALTH: I would like to standardize my hospital formulary to a single novel oral anticoagulant (NOAC). Is there evidence demonstrating the best option for treating and preventing venous thromboembolism (VTE)? – NEEDING NOAC KNOWLEDGE

READ BLOG POST

Procured Health Podcast, Episode One: Our Company Values

We are very excited to introduce our podcast, where we'll talk about the latest trends in the industry, go in-depth on the evidence for top-of-mind medical products and drugs, give you an inside look at who we are as a company, and more. 

For our first episode, Lauren Sroka on the Procured Health talent team sits down with CEO Hani Elias for a very insightful discussion about how we developed our values and how they guide our culture. 

READ BLOG POST

Exploring the Frontier of Healthcare Change: Procured Health Leadership Roundtable

Sept. 7, 2017 Clinical Leadership

A unique think tank for innovative solutions

The Procured Health Leadership Roundtable gathers top healthcare leaders in the country to collaborate, share, and solve healthcare's biggest challenges in an interactive forum. Roundtable attendees took valuable insights and actions back to their organizations.

READ BLOG POST

Evidence Insight Spotlight: The da Vinci Surgical System

The da Vinci Surgical System is a surgeon-controlled, minimally invasive robotic platform used to perform a range of complex procedures. The da Vinci Xi was introduced in 2014 to address perceived design shortcomings of its predecessor, the da Vinci Si. However, these improvements come at a higher cost. 


Download this case study to: 

• Learn what issues the da Vinci Xi was designed to address

• Explore how the Xi's modifications impact clinical and operational outcomes 

• Discover whether these outcomes justify the Xi's price tag

DOWNLOAD NOW

Ask Procured Health: Should hospitals add Entresto to formulary?

In talking to healthcare leaders about drug utilization, I’ve fielded many questions concerning the application of clinical evidence to specific drugs and drug categories. I address one popular topic below.

DEAR PROCURED HEALTH: I’m a pharmacy clinical coordinator, and my hospital’s cardiologists are clamoring for Entresto (sacubitril/valsartan) to treat patients with chronic heart failure. They point to strong efficacy data and last year’s updated American College of Cardiology/American Heart Association guidelines that recommend it over ACE inhibitors and ARBs. Should we add Entresto to our inpatient formulary? – UNCLEAR ABOUT ENTRESTO

READ BLOG POST

Case Study: Leveraging Clinical Evidence to Ensure Gown Safety, Engage Physicians on Device Selection

A news report prompted this Northeast health system to review the gowns it used to ensure the community of their safety. Additionally, the system needed to align its purchasing strategy for drug-eluting stents with the needs of the physicians at its flagship hospital.

Download this case study to: 

• Learn how this health system saved $1M through appropriate drug-eluting stent, surgical drape and gown selection

• Explore how the health system negotiated vendor pricing that exceeded their savings target by 30%

• Understand the importance of evidence in validating the safety and efficacy of devices and supplies 

DOWNLOAD NOW

Ask Procured Health: Are the latest IV iron products worth the high cost?

As I’ve talked recently to health system leaders about Procured Health’s Pharmacy solution, I’ve fielded a lot of great questions concerning the application of clinical evidence to specific drugs and drug categories. Over the next few months, I’ll highlight some of the most popular questions and answers, advice column–style.

READ BLOG POST

CCJR Spring Meeting 2017: Believe the Evidence, Not the Hype

Procured Health Senior Medical Product Specialist Simon Kerr recently attended the Current Concepts in Joint Replacement (CCJR) Spring Meeting 2017. In this blog post, Simon answers a few questions about key topics.

READ BLOG POST

Case Study: Uncovering System Wide IVIG Misuse

Intravenous immune globulins (IVIGs) represent $1.7 billion in annual spend for U.S. health systems. With nine major brands and over 100 documented off-label uses, health systems need to take a critical look at standardizing use. This case study describes how two organizations used clinical evidence to manage and enforce appropriate IVIG utilization. 

Download this case study to: 

• Learn how one health system saved $500K by eliminating multiple IVIG brands 

• Explore how an academic medical center stopped excessive off-label use

• Understand why clinical evidence is the key to tackling inappropriate drug utilization 

DOWNLOAD NOW

What do our customers say about Procured Health?

May 3, 2017 About

Courtney Bohman, Vice President of Supply Chain at LHP Hospital Group, and Leslie Flick, Executive Director at Health Future, on how Procured Health helped their health system.

WATCH VIDEO